Report Highlights

U.S. Healthcare Biometrics: Market Overview

The U.S. healthcare biometrics market generated USD 4.1 billion in 2024, spanning fingerprint, facial, iris, and palm authentication deployed for clinician logon, patient identity matching, pharmacy dispensing, and claims verification. Private vendors lead product development: Imprivata dominates hospital single sign-on with fingerprint and badge-tap authentication, while HID Global and IDEMIA supply the credential and sensor hardware. Government sets the terms of demand through the HITECH Act, which allocated roughly $27 billion for electronic health record adoption and created the access-control audit trails that biometrics now satisfy.

Policy has shaped the market's current form more than technology alone. The HIPAA Security Rule at 45 CFR Part 164 Subpart C requires unique user identification and automatic logoff, so covered entities adopted biometrics to meet access-control standards without shared passwords. Federal procurement remains government-led: the Department of Veterans Affairs and the Defense Health Agency buy identity systems through GSA schedules under NIST Special Publication 800-63-3, which classifies biometrics as an authenticator. Retail pharmacies and telehealth platforms remain private-sector led, adopting biometric verification for fraud reduction and patient convenience.

Policy-Driven Growth in U.S. Healthcare Biometrics

Three mechanisms drive demand. First, the Medicare Promoting Interoperability Program, administered by the Centers for Medicare and Medicaid Services under Section 1886(n) of the Social Security Act, ties hospital payment adjustments to certified EHR technology that requires audit logs and strong authentication. Hospitals therefore fund biometric login layers on Epic and Oracle Health workstations to protect payment eligibility. Second, Section 524B of the Federal Food, Drug, and Cosmetic Act, added by the Consolidated Appropriations Act, 2023, requires manufacturers of cyber devices to submit vulnerability monitoring plans, pushing biometric-enabled imaging and infusion equipment toward hardware-bound authentication.

Third, the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), published in January 2024, requires impacted payers to deploy patient access APIs by January 1, 2027, forcing identity proofing for member portal access. Health plans are adding facial verification through identity vendors such as Daon and IDEMIA to meet that deadline. Each mandate converts biometric authentication from optional security into a compliance prerequisite, translating directly into hardware and software purchase orders across hospitals and payers.

Regulatory Barriers and Compliance Costs

FDA premarket review under the Federal Food, Drug, and Cosmetic Act, administered by the Center for Devices and Radiological Health, imposes the first barrier. Biometric modules embedded in regulated devices require 510(k) clearance, with the MDUFA V performance goal of a 90 FDA-day review and standard user fees exceeding $20,000 per submission. Manufacturers must also produce a software bill of materials and cybersecurity documentation under Section 524B, adding months to clearance timelines.

State biometric privacy law presents the largest compliance cost. Illinois' Biometric Information Privacy Act (740 ILCS 14) requires written notice and consent before capture and is enforced through private litigation with liquidated damages of $1,000 per negligent and $5,000 per intentional violation. Texas' Capture or Use of Biometric Identifier Act is enforced by the Attorney General, who secured a $1.4 billion settlement with Meta in July 2024. HHS Office for Civil Rights penalties under HIPAA, capped at roughly $2.1 million per violation category annually, add federal enforcement exposure.

Policy-Created Opportunities in the United States

The Department of Veterans Affairs and the Defense Health Agency represent the largest procurement pool. Federal buyers purchase through GSA Federal Supply Schedules and must comply with Buy American and Trade Agreements Act requirements. GSA's Login.gov identity verification service, built to NIST 800-63-3 identity assurance level 2, sets the federal standard that authentication vendors must match, creating a qualification pathway for FedRAMP-authorized providers.

The DEA Electronic Prescribing for Controlled Substances rule (21 CFR Part 1311), mandatory since January 1, 2023, requires two-factor authentication for prescribers, and biometric factors satisfy the inherence requirement. Pharmacies and EHR vendors therefore face recurring demand for fingerprint readers at every prescribing station. The CMS-0057-F API mandate and Section 524B cybersecurity requirements extend this demand to payer portals and connected clinical devices.

Market at a Glance

Leading Market Participants

• Imprivata
• HID Global
• IDEMIA
• NEC Corporation
• Thales Group
• BIO-key International
• Suprema
• Daon
• Aware Inc.
• IrisID

Regulatory and Policy Environment

The governing statute is the Health Insurance Portability and Accountability Act of 1996 (Public Law 104-191), implemented under 45 CFR Parts 160 and 164 and enforced by the HHS Office for Civil Rights. The HIPAA Security Rule requires administrative, physical, and technical safeguards for electronic protected health information, and biometric identifiers collected in care settings fall within scope. HHS published a proposed Security Rule overhaul on January 6, 2025, which would mandate multifactor authentication and encryption; a final rule remains pending.

Compliance obligations stack across layers. Covered entities must conduct risk analyses, maintain Section 524B cybersecurity plans for connected devices, and comply with state statutes including Illinois BIPA, Texas CUBI, and Washington's My Health My Data Act, effective March 31, 2024. Compared with the EU, where GDPR Article 9 classifies biometric data as special-category data and the EU AI Act designates biometric identification systems as high-risk, the United States has no federal biometric statute, producing a state patchwork that favors vendors with configurable consent architecture.

Long-Term Policy Outlook for U.S. Healthcare Biometrics

By 2032, the most consequential change will be the finalized HIPAA Security Rule, which would make multifactor authentication mandatory for covered entities and reposition biometrics as a baseline control rather than a premium option. Illinois amended BIPA through Public Act 103-0769 in August 2024, limiting per-person recovery for repeated collection from the same individual, which reduces litigation exposure and accelerates vendor deployment in hospitals.

Federal privacy legislation remains the largest unknown. The American Privacy Rights Act stalled in Congress in 2024, so state statutes will continue shaping product design through 2032. Expect FDA to extend Section 524B-style cybersecurity expectations to digital health authentication, and TEFCA participation under The Sequoia Project to link identity verification across health information networks. Together, these shifts will move the market from state-led compliance toward national interoperability-based identity standards.